✦ LIBER ✦

Viral kinetics in hbeag positive and negative patients with HBV-related cirrhosis treated long-term with lamivudine

✍ Scribed by P. Lampertico; M. Vigano; G. Lunghi; A. Orlandi; R. Romeo; M. Iavarone; G. Colucci; E. Del Ninno; M. Colombo

Book ID: 119630471
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 165 KB
Volume: 33
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(01)80378-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The long-term effects of lamivudine trea

The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis

✍ Z. Mesut Yalin Kilic; Sedef Kuran; Meral Akdogan; Bahattin Cicek; Dilek Oguz; Bu 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 249 KB

44 The long-term outcome of HBeAg-Negati

44 The long-term outcome of HBeAg-Negative patients with cirrhosis treated with lamivudine monotherapy: A 5-year prospective cohort study

✍ P. Lampertico; M. Viganò; M. Iavarone; G. Lunghi; R. Romeo; G. Colucci; A. Morab 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Incidence of YMDD mutants, hepatocellula

Incidence of YMDD mutants, hepatocellular carcinoma and hepatic decompensation in patients with HBV-related cirrhosis treated long-term with lamivudine monotherapy

✍ P. Lampertico; M. Vigano'; R. Romeo; M. Iavarone; E. Del Ninno; M. Colombo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Incidence of YMDD mutants, hepatocellula

Incidence of YMDD mutants, hepatocellular carcinoma and hepatic decompensation in patients with HBV-related cirrhosis treated long-term with lamivudine monotherapy

✍ Lampertico, Pietro; Vigano, Mauro; Romeo, Raffaella; Del Ninno, Ersilio; Colombo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Lamivudine-resistant HBV mutants in pati

Lamivudine-resistant HBV mutants in patients with anti-HBe positive chronic hepatitis B treated with long-term lamivudine monotherapy

✍ Teresa Santantonio; Emanuele Sinisi; Maria Insalata; Emilio Palumbo; Angela Guas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Characteristics and outcome of biochemic

Characteristics and outcome of biochemical breakthroughs (BBTS) in patients with HBeAg-negative HBV related chronic liver disease [HBeAg(-)CLD] under long-term lamivudine monotherapy (LAM)

✍ George Papatheodoridis; Evangelini Dimou; Andreas Laras; Vasilios Papadimitropou 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB